Results for tag: "Hematuria Drug"

The Hematuria Drug market is a subset of the Urological Disorders Drugs market, which focuses on the treatment of diseases and disorders of the urinary tract. Hematuria drugs are used to treat conditions such as glomerulonephritis, nephrotic syndrome, and other kidney diseases. These drugs are typically administered orally or intravenously, and may include diuretics, anticoagulants, and antibiotics. They are designed to reduce the amount of blood in the urine, reduce inflammation, and prevent further damage to the kidneys. The Hematuria Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, AstraZeneca, and Sanofi. Other companies include Allergan, Bayer, and Daiichi Sankyo. Show Less Read more